Prognosis of patients with t(8;16)(p11;p13) acute myeloid leukemia

Leukemia and Lymphoma

Volumn 53, Issue 2, 2012, Pages 338-341

  Brown, Tanya ^a   Swansbury, John ^b   Taj, Mary M ^c  

^a BC CHILDREN S HOSPITAL   (Canada)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER MORTALITY; CHROMOSOME 16; CHROMOSOME 8; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 8; CYTOGENETICS; DATA BASE; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; FOLLOW UP; HUMAN; LETTER; LEUKEMOGENESIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; REMISSION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; PROGNOSIS; SURVIVAL RATE; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 84856105557     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.614703     Document Type: Letter

References (15)

1. Gibson BE, Wheatley K, Hann IM, et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005;19:2130-2138. (Pubitemid 41741605)
2. Lie SO, Abrahamsson J, Clausen N, et al. Long-term results in children with AML: NOPHO-AML Study Group-report of three consecutive trials. Leukemia 2005;19:2090-2100. (Pubitemid 41741601)
3. Smith FO, Alonzo TA, Gerbing RB, et al. Long-term results of children with acute myeloid leukemia: a report of three consecutive phase III trials by the Children ' s Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia 2005;19:2054-2062. (Pubitemid 41741597)
4. Webb DK, Wheatley K, Harrison G, et al. Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party. Leukemia 1999;13:25-31. (Pubitemid 29043713)
5. Kumar CC. Genetic abnormalities and challenges in the treatment of acute myeloid leukemia. Genes Cancer 2011;2:95-107.
6. Hasle H, Alonzo TA, Auvrignon A, et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007;109:4641-4647. (Pubitemid 46827753)
7. Lie SO, Abrahamsson J, Clausen N, et al. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down ' s syndrome: results of NOPHO-AML trials. Br J Haematol 2003;122:217-225. (Pubitemid 36859606)
8. Grimwade D, Hills RK. Independent prognostic factors for AML outcome. Hematology Am Soc Hematol Educ Program 2009:385-395.
9. Borrow J, Stanton VP Jr, Andresen JM, et al. The translocation t(8;16) (p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996;14:33-41.
10. Mo J, Lampkin B, Perentesis J, et al. Translocation (8;18;16) (p11;q21;p13). A new variant of t(8;16)(p11;p13) in acute monoblastic leukemia: case report and review of the literature. Cancer Genet Cytogenet 2006;165:75-78. (Pubitemid 43256683)
11. Becher R, Haas OA, Graeven U, et al. Translocation t(8;16) in acute monocytic leukemia. Cancer Genet Cytogenet 1988;34:265-271.
12. Haferlach T, Kohlmann A, Klein HU, et al. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia 2009;23:934-943.
13. Schmidt HH, Strehl S, Th aler D, et al. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia 2004;18:1115-1121. (Pubitemid 38786970)
14. Crowley JA, Wang Y, Rapoport AP, et al. Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation. Leukemia 2005;19:2344-2345. (Pubitemid 41741635)
15. Hanslip JI, Swansbury GJ, Pinkerton R, et al. The translocation t(8;16)(p11;p13) defines an AML subtype with distinct cytology and clinical features. Leuk Lymphoma 1992;6:479-486.